Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058969) titled 'Ex Vivo Gamma Globulin Therapy for Infertile Women with Anticentromere Autoantibodies' on Sept. 10.
Study Type: Interventional
Study Design:
Single arm Non-randomized
Primary Sponsor: Natural ART Clinic at Nihonbashi
Condition:
Anticentromere autoantibody-related female infertility
Intervention:
Ex vivo gamma globulin supplementation to culture media
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2022/07/01
Target Sample Size: 15
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067437
P...